Showing results (121-130 of 172) with videos related to
Sort By:
Pageof 18
Nature Genetics|November 13, 2007
PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesisGang Huang, Pu Zhang, Hideyo Hirai, et al.Blood|September 4, 2004
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Richard M Stone, Daniel J DeAngelo, Virginia Klimek, et al.Blood|June 10, 2011
Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specificationMelanie G Cornejo, Vinciane Mabialah, Stephen M Sykes, et al.Cancer Cell|June 28, 2002
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemiaAdolfo A Ferrando, Donna S Neuberg, Jane Staunton, et al.Blood|July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapyAnimesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.Blood|July 27, 2006
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patientsAnimesh D Pardanani, Ross L Levine, Terra Lasho, et al.Cell|January 27, 2007
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stressZuzana Tothova, Ramya Kollipara, Brian J Huntly, et al.Blood|January 25, 2008
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenesGerlinde Wernig, Jeffrey R Gonneville, Brian J Crowley, et al.Cell Stem Cell|September 11, 2012
mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesisDemetrios Kalaitzidis, Stephen M Sykes, Zhu Wang, et al.Blood|January 14, 2009
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation modelsMelanie G Cornejo, Michael G Kharas, Miriam B Werneck, et al.Pageof 18